The newsroom includes access to CHA News, which provides timely information to members every Thursday and is at the core of CHA benefits. In addition, it is also home to resources such as toolkits and talking points designed to help member hospitals and health systems communicate with internal and external audiences on a range of current health care-related issues. Links to CHA media statements and press releases can also be found here.
Newsroom
CHA Issues Summary of Proposed Notice of Benefit and Payment Parameters for 2023
CHA has issued a members-only summary, prepared by Health Policy Alternatives, Inc., of the proposed notice of benefit and payment parameters for 2023 issued by the Centers for Medicare & Medicaid Services (CMS). Comments are due to CMS by 2 p.m. (PT) on Jan. 27.
CMS Issues Proposed Rule for 2023 Medicare Advantage and Part D Plans
The Centers for Medicare & Medicaid Services (CMS) has issued its proposed rule for the 2023 Medicare Advantage (MA) and Part D plan year.
DHCS Releases CalAIM Major Organ Transplant Guidance
Based on requests from stakeholders, including CHA, the Department of Health Care Services has released guidance on the reimbursement requirements associated with the California Advancing and Innovating Medi-Cal (CalAIM) major organ transplant changes.
CMS Releases Additional Resources Related to No Surprises Act Independent Dispute Resolution Process
The Centers for Medicare & Medicaid Services (CMS) has released additional resources that can help facilities and providers prepare for the independent dispute resolution (IDR) process included in the No Surprises Act (NSA), which took effect on Jan. 1.
CMS Issues New HCPCS Code for Remdesivir Antiviral Medication
The Centers for Medicare & Medicaid Services (CMS) released a new Healthcare Common Procedure Coding System (HCPCS) code for VEKLURY™ (remdesivir) antiviral medication when administered in an outpatient setting.
Supply, Access to Monoclonal Antibody, Oral Antiviral Treatments Varies
Over the past several weeks, the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) has made several changes and updates to the distribution and allocation of currently available treatments for COVID-19, including monoclonal antibodies and oral antivirals.
Governor Signs Executive Order to Prevent Price Gouging on At-Home COVID Tests
On Jan. 8, Gov. Newsom signed Executive Order N-2-22, outlawing price-gouging for at-home COVID-19 test kits until March 31, 2022. Specifically, sellers of these tests may not charge a price that is more than 10% greater than the price they charged on Dec. 1, 2021, unless:
HHS Updates COVID-19 Reporting Requirements
On Jan. 6, the U.S. Department of Health and Human Services (HHS) updated its COVID-19 hospital reporting requirements (see the HHS FAQs) in response to changes in the pandemic.
CDC Endorses Boosters for Younger Adolescents
On Jan. 5, the Centers for Disease Control and Prevention (CDC) endorsed the recommendation made earlier that day by its Advisory Committee on Immunization Practices that eligibility for a single booster dose of the Pfizer-BioNTech vaccine be expanded to ages 12-15.
CDPH Issues All Facilities Letters on Fair Pricing and Debt Collection, CNAs
The California Department of Public Health (CDPH) has issued two All Facilities Letters (AFL) related to hospital fair pricing policies and debt collection procedures and certified nurse assistants.